Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Alibaba Hong Kong Entrepreneurs Fund’s JUMPSTARTER Launches Global Pitch Competition

Published

on

Reading Time: 4 minutes

 

Alibaba Hong Kong Entrepreneurs Fund, a non-profit initiative launched by Alibaba Group Holding Ltd., today kicked off the application process for JUMPSTARTER, its signature start-up event in Hong Kong. This year, JUMPSTARTER is, for the first time, hosting a global pitch competition, with pitching events in Hong KongShenzhenShanghaiBeijingKuala LumpurLondonSan Francisco and Toronto. The aim is to connect global talent, start-ups and entrepreneurs with JUMPSTARTER’s highly competitive Hong Kong Grand Finale to take place within StartmeupHK Festival on February 11-12, 2020.

The campaign will provide up to a combined US$5 million investment commitment and US$100,000 in cash to the top five JUMPSTARTER start-ups.

In partnership with InvestHK, Hong Kong Exchanges and Clearing Ltd (HKEX), Cyberport and Hong Kong Science and Technology Parks Corporation (HKSTP), JUMPSTARTER will not only provide capital to winning start-ups, but also offer networking opportunities with top investors, corporates and other start-ups. As a part of InvestHK’s StartmeupHK Festival, JUMPSTARTER provides a platform that brings start-ups, entrepreneurs, corporates and investors to build, empower and boost connections among different ecosystems and international tech hubs. Top JUMPSTARTER companies will also get access to the Alibaba ecosystem to help them gain valuable insight, experience and resources to expand their businesses. (See appendix for quotes from the global co-organizer and the co-organizers)

The third JUMPSTARTER is taking the event to a new level with the introduction of eight pitching events in Hong Kongand seven other international cities from August to November 2019. Each event is expected to host over 100 start-ups, and 40 finalists from these global locations will be given the opportunity to participate in the JUMPSTARTER Grand Finale in Hong Kong in February 2020. These events will attract rising stars interested in the Hong Kong and Asiamarkets and further enhance Hong Kong’s position as a start-up hub for the region.

One of the highlights of JUMPSTARTER is a start-up competition featuring young companies from four sectors ­– retail, fintech, smart city and advanced technology — viewed as key to Hong Kong’s long-term economic development. In particular, JUMPSTARTER provides more exposure for fintech start-ups. For fintech start-ups that apply for the JUMPSTARTER competition, they will also automatically be entered into FintechHK Global Competition, organized by InvestHK, in November 2019 during Hong Kong Fintech Week. (See appendix for the application requirement and timeline)

“Our immensely successful second JUMPSTARTER early this year attracted 10,000 attendees with over 600 business proposals. By substantially expanding the scale of the competition with start-up pitching events across the Asia PacificCanadaEurope and the U.S., we are truly putting JUMPSTARTER on the global stage, welcoming incredible young entrepreneurs from around the world and connecting them with amazing opportunities,” said Cindy Chow, Executive Director of Alibaba Hong Kong Entrepreneurs Fund.

“We look forward to empowering start-ups, regardless of their home base, and are excited to embark on new journeys together with them leveraging the unique Hong Kong advantage. Through our third JUMPSTARTER, we join hands with InvestHK, HKEX, Cyberport and HKSTP, who share a common belief with us that Hong Kong is a regional powerhouse for start-ups. We hope to continue to foster an environment in the city that embraces entrepreneurial spirit and we are ready to unleash the potential of innovations and entrepreneurship around the globe,” added Chow.

JUMPSTARTER is open for applications from today. Interested parties can visit www.jumpstarter.hk for more information.

Appendix – Quotes from Global Co-organizer and Co-organizers of JUMPSTARTER 2020

Global Co-organizer:

Stephen Phillips, Director-General of InvestHK, said: “The two flagship events spearheaded by InvestHK – Hong Kong Fintech Week and StartmeupHK Festival – are a perfect tie-in with JUMPSTARTER. We look forward to collaborating closely with Alibaba Entrepreneurs Fund in the coming months. The final pitch of the FintechHK Global Competition will take place on November 6, 2019 at Hong Kong Fintech Week, and the Grand Finale of the JUMPSTARTER Global Pitch Competition next February. With an increasing number of startups across the globe seeing impressive and explosive growth across all kinds of industries, we stand ready to support their journey in scaling their business globally via Hong Kong.”

Co-organizers:

Charles Li, Chief Executive of HKEX, said: “It is our vision to be the global markets leader in the Asian time zone — connecting China, connecting the world. We are delighted to be supporting JUMPSTARTER in helping them attract quality startups and talents to Hong Kong, and look forward to working with them in promoting Hong Kong as a world-leading centre for entrepreneurship, fundraising and IPOs.”

Peter Yan, Chief Executive Officer of Cyberport, said: “Cyberport is committed to nurturing youth, start-ups and entrepreneurs to grow in the digital tech industry by connecting them to strategic partners and investors. The Global Pitch Competition by JUMPSTARTER aligns with our aim to promote Hong Kong as a hub for innovation and technology that connects quality start-ups, corporates and investors, and empower Hong Kong’s start-up community.”

Albert Wong, Chief Executive Officer of HKSTP, said: “Hong Kong Science Park is of full commitment that we strive to co-create with various stakeholders to our ever-growing I&T ecosystem, and may this empower our start-ups continue to grow and succeed by crystallising ideas into solutions. With JUMPSTARTER that connects tech hubs around the world, it further promotes a message to the world of Hong Kong as an international I&T hub and destination for global companies and talent to seek new opportunities while bringing our home-grown companies and solutions out to the world.”

Appendix – JUMPSTARTER application requirement and timeline

Application requirement

If your start-ups fulfil the following requirements, you are eligible to apply:

  • Less than 5 years old
  • Have raised less than US$20 million in funding
  • Start-up funding is between Seed and Series C stage
  • Possess a ground-breaking and innovative product or service
  • Desire to make Hong Kong part of your future plans

 

SOURCE Alibaba Group

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending